Evidence check: Östradiol in the context of Blutzucker

Estradiol (E2) modulates insulin sensitivity and glucose homeostasis through multiple mechanisms. In premenopausal women, estradiol generally enhances insulin action by promoting GLUT4 translocation in muscle and regulating hepatic glucose output. After menopause, declining E2 levels correlate with increased insulin resistance and impaired fasting glucose. However, the evidence is moderate: most data come from observational studies or animal models. Randomized trials on hormone replacement therapy (HRT) show mixed results, with effects depending on route (oral vs. transdermal), progestin type, and individual metabolic status. A direct causal effect on blood glucose is not firmly established. For consumers using home tests (e.g., MyBody-X), a single estradiol measurement without cycle timing, age, and metabolic markers is insufficient to assess glucose regulation. Combining it with HbA1c, fasting glucose, and insulin would be more informative. Safety note: hormonal self-experimentation without medical supervision carries risks.